Review
Accepted on 13 May 2025
Tight junctional protein family, Claudins (CLDNs) in cancer and cancer metastasis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1596460
Type at least 3 characters
3,017 articles
Mini Review
Accepted on 12 May 2025
Senescence-Associated Secretory Phenotype in Lung Cancer: Remodeling the Tumor Microenvironment for Metastasis and Immune Suppression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1605085
Correction
Published on 12 May 2025
Corrigendum: Canmei formula reduces colitis-associated colorectal carcinogenesis in mice by modulating the composition of gut microbiota
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1609683
- 224 views
Original Research
Accepted on 06 May 2025
Comprehensive Simulations of Intracellular Electric Fields during Exposure to Tumor Treating Fields (TTFields)
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1520504
Review
Accepted on 06 May 2025
The Dual Effects of Macrophage-Derived Extracellular Vesicles on Tumor Cell Behavior: Mechanisms and Clinical Potential
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1586083
Original Research
Accepted on 06 May 2025
Digital Spatial Profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1572299
Original Research
Published on 06 May 2025
COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1570727
- 404 views
Review
Accepted on 05 May 2025
Current Trends in Theranostic Applications of Extracellular Vesicles in Cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1592006
Review
Accepted on 30 Apr 2025
Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1598934
Original Research
Accepted on 30 Apr 2025
Curcumin Inhibits Colorectal Cancer Progression by Targeting PTBP1 and CDK2-Mediated Pathways
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1566889
Review
Accepted on 29 Apr 2025
Research Progress on the Cross-regulation Between Ferroptosis and Immunogenic Cell Death in Tumor Micro-environment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1581951
- 102 views
Hypothesis and Theory
Accepted on 29 Apr 2025
Th17-to-Th1 Plasticity Under CTLA-4 Blockade: A Double-Edged Sword in Tumor Immunity and Mucosal Defense
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1607671
Review
Published on 29 Apr 2025
MYCN as an oncogene in pediatric brain tumors
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1584978
- 571 views
Original Research
Accepted on 28 Apr 2025
METTL3-mediated SNHG1 m 6 A modification promotes proliferation and migration by transcriptional regulation of WDR74 in osteosarcoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1529657
Original Research
Accepted on 28 Apr 2025
Multifactorial Risk Stratification for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Predictive Model Integrating Clinical and Tumor Characteristics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1586307
Original Research
Accepted on 28 Apr 2025
SerpinE2 promotes M2 polarization in macrophage to accelerate colorectal cancer progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1585935
- 117 views